(1 - 12 from 16
)
A triumph for injectable PrEP, but a sobering result for oral PrEP
www.aidsmap.com
Jan 27, — Professor Sinead Delany-Moretlwe presenting HPTN 084's study design. Women taking long-acting injections of cabotegravir had 89% fewer HIV ... › news › jan › triumph...
Co-Chair's choice - AIDS programme
programme.aids2022.org
Jul 29, — Long acting cabotegravir: updated efficacy and safety results from HPTN Sinead DELANY-MORETLWE, University of the Witwatersrand, ... › Programme › Session
Kenya to Conduct Trial on New HIV Prevention Drug for Women
genderandaids.unwomen.org
“The development of safe alternative options for PrEP could increase HIV prevention choices for women,” said Sinead Delany-Moretlwe, chair of the study at the Witwatersrand in Johannesburg, South Africa. HPTN 084 trial is jointly funded through a partnership of the US National Institute of Allergy and ...
sorted by relevance / date